Objective To explore the graft versus leukemia effects of donor lymphocyte infusion(DLI) after nonmyeloablative allogeneic bone marrow transplantation while attenuating treatment associated morbidity, mortality and graft versus host disease.

• 目的 探讨非清除性异基因骨髓移植 (allo BMT)后供者淋巴细胞输注 (DLI)是否能减少移植相关并发症、相关死亡和减轻移植物抗宿主病 (GVHD) ,是否能增强移植物抗白血病 (GVL)效应。